Coverage
-
April 29, 2026
A stipulation between state attorneys general and private plaintiffs suing generic drugmakers for alleged price-fixing seems to reflect a change in the states' earlier deal to release claims against Bausch entities, the companies said in asking a Connecticut federal judge to maintain the status quo.
53 other articles on this case.
View all »